Potential Modulatory Microbiome Therapies for Prevention or Treatment of Inflammatory Bowel Diseases
A disturbed interaction between the gut microbiota and the mucosal immune system plays a pivotal role in the development of inflammatory bowel disease (IBD). Various compounds that are produced by the gut microbiota, from its metabolism of diverse dietary sources, have been found to possess anti-inf...
Saved in:
Main Authors: | Daan V. Bunt (Author), Adriaan J. Minnaard (Author), Sahar El Aidy (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Role of Gut Microbiome in Initiation of Inflammatory Bowel Disease; A Review
by: Taher Azimi, et al.
Published: (2020) -
Gut microbiome-based therapeutics in inflammatory bowel disease
by: Kelly A. Hu, et al.
Published: (2023) -
Potential Use of Antioxidant Compounds for the Treatment of Inflammatory Bowel Disease
by: Alexander V. Blagov, et al.
Published: (2023) -
Probiotics, prebiotics, synbiotics in prevention and treatment of inflammatory bowel diseases
by: Tanja Petreska Ivanovska, et al.
Published: (2014) -
Alterations and Potential Applications of Gut Microbiota in Biological Therapy for Inflammatory Bowel Diseases
by: Dan Pu, et al.
Published: (2022)